[{"Assets_0_Q2_USD":174719000.0,"EarningsPerShareBasic_1_Q2_USD":-1.08,"EarningsPerShareBasic_2_Q2_USD":-0.92,"EarningsPerShareDiluted_1_Q2_USD":-1.08,"EarningsPerShareDiluted_2_Q2_USD":-0.92,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-49428000.0,"NetIncomeLoss_1_Q2_USD":-28211000.0,"NetIncomeLoss_2_Q2_USD":-24129000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":7571000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":39962000.0,"StockholdersEquity_0_Q2_USD":-167874000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":26178793.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":26167033.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":26178793.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":26167033.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]